Diabetes Specialists Value Continuous Glucose Monitoring Despite Challenges in Prescribing and Data Review Process
Authors' conclusion
Despite uniform support for CGM by providers, ongoing challenges related to cost, insurance coverage, and difficulties with prescription were major barriers to CGM use. Increased use of CGM in appropriate populations will necessitate improvements in data access and integration, clearly defined workflows, and decreased administrative burden to obtain CGM.
Study context
- Population
- Providers caring for people with diabetes; 73.2% at academic centers, 70.6% endocrinologists, 70.7% urban
- Participants
- 182 survey respondents
- Outcome
- CGM-related opinions, prescription and data review practices
Methodological detailsnational survey
- National survey
Main finding
As reported in the abstract
- Providers reporting continuous glucose monitoring (CGM) use in the majority of their T1D patients
- Nearly 70%
- Providers reporting CGM use in 10% to 50% of their T2D patients
- Half
- Reviewed CGM data each visit
- 97.7%
- Actively involved patients in data interpretation
- 98.8%
- Reviewed CGM data outside visits without prompting from patients or family
- 14.1%
- CGM data review valued by patients
- 80.7%
- Adequate time for data review
- 45.1%
- Efficient process for data review
- 56.1%
Observational data: associations, not effects.
Original publication
Diabetes Specialists Value Continuous Glucose Monitoring Despite Challenges in Prescribing and Data Review Process. J Diabetes Sci Technol. Published 11 April 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →